{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:37Z","timestamp":1786985617999,"version":"build-2736575974"},"reference-count":230,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217701","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:29:28Z","timestamp":1744003768000},"page":"217701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Intersection between lung cancer and neuroscience: Opportunities and challenges"],"prefix":"10.1016","volume":"621","author":[{"given":"Xiang","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","article-title":"Nerve dependence: from regeneration to cancer","volume":"31","author":"Boilly","year":"2017","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2012.08.003","article-title":"Nerve dependence in tissue, organ, and appendage regeneration","volume":"35","author":"Kumar","year":"2012","journal-title":"Trends Neurosci."},{"issue":"7965","key":"10.1016\/j.canlet.2025.217701_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","article-title":"The neuroscience of cancer","volume":"618","author":"Mancusi","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"issue":"10299","key":"10.1016\/j.canlet.2025.217701_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib8","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"issue":"1\u201310","key":"10.1016\/j.canlet.2025.217701_bib10","article-title":"Current knowledge of small cell lung cancer transformation from non-small cell lung cancer","volume":"94","author":"Giaccone","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217701_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216986","article-title":"Crosstalk between the nervous system and tumor microenvironment: functional aspects and potential therapeutic strategies","volume":"594","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"15\u201316","key":"10.1016\/j.canlet.2025.217701_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1101\/gad.338228.120","article-title":"Cells of origin of lung cancers: lessons from mouse studies","volume":"34","author":"Ferone","year":"2020","journal-title":"Genes & Development"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2019.09.010","article-title":"Rare pulmonary neuroendocrine cells are stem cells regulated by Rb, p53, and notch","volume":"179","author":"Ouadah","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","article-title":"Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung","volume":"19","author":"Sutherland","year":"2011","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccr.2010.12.021","article-title":"A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer","volume":"19","author":"Calbo","year":"2011","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.canlet.2025.217701_bib16","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1101\/gad.262998.115","article-title":"Paracrine signaling between tumor subclones of mouse SCLC: a critical role of ETS transcription factor Pea3 in facilitating metastasis","volume":"29","author":"Kwon","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.217701_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114277","article-title":"Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: impact of immunotherapy on overall survival in a real-life setting","volume":"210","author":"Falchero","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217701_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50616","article-title":"Axon-like protrusions promote small cell lung cancer migration and metastasis","volume":"8","author":"Yang","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2025.217701_bib19","first-page":"OF1","article-title":"Sympathetic neurons promote small cell lung cancer through the \u03b22-adrenergic receptor","author":"Fnu","year":"2025","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtho.2018.08.2028","article-title":"A brief report of transformation from NSCLC to SCLC: molecular and therapeutic characteristics","volume":"14","author":"Ferrer","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jtho.2019.11.005","article-title":"The evolving landscape of resistance to osimertinib","volume":"15","author":"Schoenfeld","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1158\/2159-8290.CD-18-1022","article-title":"Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion","volume":"8","author":"Piotrowska","year":"2018","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.canlet.2025.217701_bib23","article-title":"Tissue-based molecular and histological landscape of acquired resistance to osimertinib given initially or at relapse in patients with EGFR-mutant lung cancers","volume":"37","author":"Schoenfeld","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib24","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/2159-8290.CD-20-1863","article-title":"Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation","volume":"11","author":"Quintanal-Villalonga","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.217701_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216647","article-title":"Notch signaling and targeted therapy in non-small cell lung cancer","volume":"585","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"issue":"24","key":"10.1016\/j.canlet.2025.217701_bib26","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"281","key":"10.1016\/j.canlet.2025.217701_bib181","article-title":"Understanding lineage plasticity as a path to targeted therapy failure in EGFR-mutant non-small cell lung cancer","volume":"11","author":"Shaurova","year":"2020","journal-title":"Front. Genet."},{"issue":"6410","key":"10.1016\/j.canlet.2025.217701_bib182","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aat5749","article-title":"Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage","volume":"362","author":"Park","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib183","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.29835","article-title":"NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas","volume":"138","author":"Meder","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib184","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41388-019-0997-x","article-title":"SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K\/AKT\/SOX2 axis and beyond","volume":"39","author":"Schaefer","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.121550","article-title":"Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer","volume":"15","author":"Mosquera","year":"2013","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib187","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41598-024-55604-6","article-title":"Acetylcholinesterase enzyme among cancer patients a potential diagnostic and prognostic indicator a multicenter case-control study","volume":"14","author":"Ahmed","year":"2024","journal-title":"Sci. Rep."},{"issue":"111217","key":"10.1016\/j.canlet.2025.217701_bib42","article-title":"Tumor-derived GABA promotes lung cancer progression by influencing TAMs polarization and neovascularization","volume":"126","author":"Dong","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"29","key":"10.1016\/j.canlet.2025.217701_bib43","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/1759-7714.15075","article-title":"AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines","volume":"14","author":"Masumoto","year":"2023","journal-title":"Thorac Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cell.2016.05.052","article-title":"Nfib promotes metastasis through a widespread increase in chromatin accessibility","volume":"166","author":"Denny","year":"2016","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib45","first-page":"457","article-title":"Thrombospondin-1 promotes alpha3beta1 integrin-mediated adhesion and neurite-like outgrowth and inhibits proliferation of small cell lung carcinoma cells","volume":"60","author":"Guo","year":"2000","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib52","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192732","article-title":"Multifunctional neuron-specific enolase: its role in lung diseases","volume":"39","author":"Xu","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010436","article-title":"Somatostatin and somatostatin receptors in tumour biology","volume":"25","author":"Kumar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1535-7163.MCT-21-0851","article-title":"ABBV-011, A novel, calicheamicin-based antibody-drug conjugate, targets SEZ6 to eradicate small cell lung","volume":"21","author":"Wiedemeyer","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03202-9","article-title":"Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer","volume":"43","author":"Zheng","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102531","article-title":"Adenocarcinomas of the lung and neurotrophin system: a review","volume":"10","author":"Ricci","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1759-7714.12374","article-title":"Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma","volume":"7","author":"Shao","year":"2016","journal-title":"Thorac Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib29","first-page":"502","article-title":"[General aspects of pulmonary innervation]","volume":"149","author":"Arreola-Ramirez","year":"2013","journal-title":"Gac. Med. Mex."},{"key":"10.1016\/j.canlet.2025.217701_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119259","article-title":"Electroacupuncture regulates inflammatory cytokines by activating the vagus nerve to enhance antitumor immunity in mice with breast tumors","volume":"272","author":"Zhang","year":"2021","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib31","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/biology12111418","article-title":"Acetylcholine, Another factor in breast cancer","volume":"12","author":"Mu\u00f1OZ","year":"2023","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1541-7786.MCR-24-0265","article-title":"Small cell lung cancer neuronal features and their implications for tumor progression, metastasis, and therapy","volume":"22","author":"Hartmann","year":"2024","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib33","doi-asserted-by":"crossref","DOI":"10.2217\/lmt-2023-0006","article-title":"Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies","volume":"12","author":"Garramona","year":"2023","journal-title":"Lung Cancer Manag"},{"key":"10.1016\/j.canlet.2025.217701_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1374236","article-title":"A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options","volume":"15","author":"Yuan","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/alr.23079","article-title":"International consensus statement on obstructive sleep apnea","volume":"13","author":"Chang","year":"2023","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11325-021-02369-1","article-title":"Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages","volume":"26","author":"Liu","year":"2022","journal-title":"Sleep Breath."},{"issue":"110251","key":"10.1016\/j.canlet.2025.217701_bib37","article-title":"Psychological distress influences lung cancer: advances and perspectives on the immune system and immunotherapy","volume":"121","author":"Gui","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/j.pain.0000000000001175","article-title":"Heterozygous mutations in GTP-cyclohydrolase-1 reduce BH4 biosynthesis but not pain sensitivity","volume":"159","author":"Nasser","year":"2018","journal-title":"Pain"},{"issue":"660","key":"10.1016\/j.canlet.2025.217701_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1531","article-title":"Phenotypic drug screen uncovers the metabolic GCH1\/BH4 pathway as key regulator of EGFR\/KRAS-mediated neuropathic pain and lung cancer","volume":"14","author":"Cronin","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","article-title":"Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression","volume":"24","author":"Huang","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"13","key":"10.1016\/j.canlet.2025.217701_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25133093","article-title":"The GABA(B) receptor-structure, ligand binding and drug development","volume":"25","author":"Evenseth","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib46","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.celrep.2019.05.057","article-title":"Tumor heterogeneity underlies differential cisplatin sensitivity in mouse models of small-cell lung cancer","volume":"27","author":"B\u00f6TTGER","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccell.2019.09.002","article-title":"ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures","volume":"36","author":"Qadeer","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4161\/cam.4.1.10882","article-title":"Guidance molecules in lung cancer","volume":"4","author":"Nasarre","year":"2010","journal-title":"Cell Adh Migr"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1200\/JCO.2010.33.3716","article-title":"Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer","volume":"30","author":"Hou","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1471-4159.1978.tb07847.x","article-title":"Functional properties of neuronal and glial isoenzymes of brain enolase","volume":"31","author":"Marangos","year":"1978","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-11-524","article-title":"Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide","volume":"11","author":"Yan","year":"2011","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.canlet.2025.217701_bib53","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.7314\/APJCP.2014.15.22.9611","article-title":"Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"1\u20136","key":"10.1016\/j.canlet.2025.217701_bib54","article-title":"Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer","volume":"194","author":"Jiang","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12957-020-01894-9","article-title":"Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis","volume":"18","author":"Tian","year":"2020","journal-title":"World J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib56","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.21037\/jtd.2019.04.29","article-title":"Diagnostic value of ProGRP for small cell lung cancer in different stages","volume":"11","author":"Dong","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.canlet.2025.217701_bib57","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.2147\/OTT.S228301","article-title":"Third-generation TKI resistance due to SCLC transformation: a case report and brief review","volume":"12","author":"Chen","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2025.217701_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2023.115132","article-title":"Dual-quenching electrochemiluminescence resonance energy transfer system from CoPd nanoparticles enhanced porous g-C3N4 to FeMOFs-sCuO for neuron-specific enolase immunosensing","volume":"226","author":"Hu","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.canlet.2025.217701_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.339609","article-title":"Electrochemical neuron-specific enolase (NSE) immunosensor based on CoFe2O4@Ag nanocomposite and AuNPs@MoS2\/rGO","volume":"1200","author":"Karaman","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib60","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/ijc.31771","article-title":"Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer","volume":"144","author":"Lehman","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11102-006-7822-6","article-title":"Antiproliferative effects of somatostatin analogs in pituitary adenomas","volume":"9","author":"Zatelli","year":"2006","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib62","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.2967\/jnumed.123.265664","article-title":"68Ga-SSO-120 PET for initial staging of small cell lung cancer patients: a single-center retrospective study","volume":"64","author":"Kersting","year":"2023","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib63","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1158\/1535-7163.MCT-23-0029","article-title":"RYZ101 (Ac-225 DOTATATE) opportunity beyond gastroenteropancreatic neuroendocrine tumors: preclinical efficacy in small-cell lung cancer","volume":"22","author":"Han","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib64","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1021\/acs.molpharmaceut.3c00427","article-title":"Effective treatment of SSTR2-positive small cell lung cancer using (211)At-containing targeted \u03b1-particle therapy agent which promotes endogenous antitumor immune response","volume":"20","author":"Qin","year":"2023","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib65","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1158\/1535-7163.MCT-19-0022","article-title":"Targeting the somatostatin receptor 2 with the miniaturized drug conjugate, PEN-221: a potent and novel therapeutic for the treatment of small cell lung cancer","volume":"18","author":"Whalen","year":"2019","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/RLU.0000000000004591","article-title":"Somatostatin receptor-directed PET\/CT for therapeutic decision-making and disease control in patients affected with small cell lung cancer","volume":"48","author":"Serfling","year":"2023","journal-title":"Clin. Nucl. Med."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004854","article-title":"Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors","volume":"10","author":"Mandriani","year":"2022","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.neuron.2007.09.018","article-title":"Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons","volume":"56","author":"Gunnersen","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib70","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/s41467-023-39420-6","article-title":"Schizophrenia-associated NRXN1 deletions induce developmental-timing- and cell-type-specific vulnerabilities in human brain organoids","volume":"14","author":"Sebastian","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217701_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.608442","article-title":"Insights into the role and potential of schwann cells for peripheral nerve repair from studies of development and injury","volume":"13","author":"Balakrishnan","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"13","key":"10.1016\/j.canlet.2025.217701_bib74","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1113\/JP270874","article-title":"The repair Schwann cell and its function in regenerating nerves","volume":"594","author":"Jessen","year":"2016","journal-title":"Journal of Physiology-London"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jnc.15877","article-title":"Single-cell RNA-seq uncovers novel metabolic functions of Schwann cells beyond myelination","volume":"166","author":"Eid","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.canlet.2025.217701_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216689","article-title":"Schwann cells in pancreatic cancer: unraveling their multifaceted roles in tumorigenesis and neural interactions","volume":"587","author":"Cai","year":"2024","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib77","doi-asserted-by":"crossref","first-page":"S673","DOI":"10.1016\/j.jtho.2019.08.1428","article-title":"P2.01-85 schwann cells are overexpressed and inversely correlated with survival of non-small cell lung cancer patients","volume":"14","author":"Zhou","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200089","article-title":"The role of schwann cells in cancer","volume":"6","author":"Deborde","year":"2022","journal-title":"Advanced Biology"},{"key":"10.1016\/j.canlet.2025.217701_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1365760","article-title":"Schwann cells in the normal and pathological lung microenvironment","volume":"11","author":"Shurin","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.canlet.2025.217701_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104211","article-title":"Schwann cells promote lung cancer proliferation by promoting the M2 polarization of macrophages","volume":"357","author":"Zhou","year":"2020","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7150\/ijbs.86085","article-title":"VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"20","key":"10.1016\/j.canlet.2025.217701_bib82","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/0008-5472.CAN-18-1702","article-title":"Schwann cells augment cell spreading and metastasis of lung cancer","volume":"78","author":"Zhou","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217701_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216667","article-title":"SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP\/TAZ signaling pathway","volume":"585","author":"Zhang","year":"2024","journal-title":"Cancer Lett."},{"issue":"42\u201356","key":"10.1016\/j.canlet.2025.217701_bib84","article-title":"2-Methylthio conversion of N6-isopentenyladenosine in mitochondrial tRNAs by CDK5RAP1 promotes the maintenance of glioma-initiating cells","volume":"21","author":"Yamamoto","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2025.217701_bib85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bbrc.2021.03.172","article-title":"Adrenergic signaling promotes the expansion of cancer stem-like cells of malignant peripheral nerve sheath tumors","volume":"557","author":"Huang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib86","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","article-title":"The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells","volume":"147","author":"Cordenonsi","year":"2011","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib87","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/cas.16164","article-title":"Adrenergic microenvironment driven by cancer\u2010associated Schwann cells contributes to chemoresistance in patients with lung cancer","volume":"115","author":"Otani","year":"2024","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib88","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/glia.24497","article-title":"Schwann cell-derived exosomes promote lung cancer progression via miRNA-21-5p","volume":"72","author":"Zhou","year":"2024","journal-title":"Glia"},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib89","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1158\/0008-5472.CAN-20-3326","article-title":"Peripheral nerve resident macrophages and schwann cells mediate cancer-induced pain","volume":"81","author":"De Logu","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091261","article-title":"Transient receptor potential ankyrin 1 (TRPA1) channel as a sensor of oxidative stress in cancer cells","volume":"12","author":"Moccia","year":"2023","journal-title":"Cells"},{"issue":"14","key":"10.1016\/j.canlet.2025.217701_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411847","article-title":"Transient receptor potential ankyrin 1 (TRPA1) channel mediates acrolein cytotoxicity in human lung cancer cells","volume":"24","author":"Sakamoto","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020304","article-title":"Endolysosomal cation channels and lung disease","volume":"11","author":"Spix","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib93","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.21037\/tlcr-24-888","article-title":"Construction and validation of a prognostic model based on oxidative stress-related genes in non-small cell lung cancer (NSCLC): predicting patient outcomes and therapy responses","volume":"13","author":"Sun","year":"2024","journal-title":"Transl. Lung Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib94","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib95","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ccell.2018.05.001","article-title":"Cancer cells Co-opt the neuronal redox-sensing channel TRPA1 to promote oxidative-stress tolerance","volume":"33","author":"Takahashi","year":"2018","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.canlet.2025.217701_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246132","article-title":"A novel therapeutic target for small-cell lung cancer: tumor-associated repair-like schwann cells","volume":"14","author":"Cao","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib97","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.devcel.2009.07.009","article-title":"The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain","volume":"17","author":"Zhao","year":"2009","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147276","article-title":"Tumor innervation: peripheral nerves take control of the tumor microenvironment","volume":"131","author":"Gysler","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib99","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.trecan.2020.07.005","article-title":"Tumor innervation: cancer has some nerve","volume":"6","author":"Reavis","year":"2020","journal-title":"Trends in Cancer"},{"issue":"20","key":"10.1016\/j.canlet.2025.217701_bib100","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1002\/cncr.32772","article-title":"Neurologic complications of lung cancer","volume":"126","author":"Sands","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib101","article-title":"Overview of paraneoplastic autoantibody-mediated cognitive impairment and behavioral changes: a narrative review","volume":"16","author":"Alkhayat","year":"2024","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib102","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"7\u201321","key":"10.1016\/j.canlet.2025.217701_bib103","article-title":"Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies","volume":"16","author":"Nguyen","year":"2023","journal-title":"Int. J. Gen. Med."},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib104","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41571-023-00808-4","article-title":"Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer","volume":"20","author":"Pan","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s40425-019-0803-x","article-title":"Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature","volume":"7","author":"Carausu","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib106","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1148\/rg.2020200012","article-title":"Anatomy, imaging, and pathologic conditions of the brachial plexus","volume":"40","author":"Gilcrease-Garcia","year":"2020","journal-title":"Radiographics"},{"issue":"Suppl 2","key":"10.1016\/j.canlet.2025.217701_bib107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/resp.13870","article-title":"Radiotherapy treatment for lung cancer: current status and future directions","volume":"25","author":"Vinod","year":"2020","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib108","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s12264-023-01020-1","article-title":"Hippocampus: molecular, cellular, and circuit features in anxiety","volume":"39","author":"Shi","year":"2023","journal-title":"Neurosci. Bull."},{"issue":"34","key":"10.1016\/j.canlet.2025.217701_bib109","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (rtog 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.canlet.2025.217701_bib110","doi-asserted-by":"crossref","first-page":"16992","DOI":"10.1021\/acsami.7b19013","article-title":"Anti-EGFR peptide-conjugated triangular gold nanoplates for computed tomography\/photoacoustic imaging-guided photothermal therapy of non-small cell lung cancer","volume":"10","author":"Zhao","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"19","key":"10.1016\/j.canlet.2025.217701_bib111","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1158\/0008-5472.CAN-15-3196","article-title":"An integrated nanotechnology-enabled transbronchial image-guided intervention strategy for peripheral lung cancer","volume":"76","author":"Jin","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib112","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.21037\/jtd-24-158","article-title":"Post-thoracotomy pain syndrome in the era of minimally invasive thoracic surgery","volume":"16","author":"Miyazaki","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib113","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ejcts\/ezaa258","article-title":"Nerve at risk: anatomical variations of the left recurrent laryngeal nerve and implications for thoracic surgeons","volume":"58","author":"Ng","year":"2020","journal-title":"Eur. J. Cardio. Thorac. Surg."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib114","article-title":"Effect of prehabilitation in lung cancer patients undergoing lobectomy: a review","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.canlet.2025.217701_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102807","article-title":"Central nervous system metastases in advanced non-small cell lung cancer: a review of the therapeutic landscape","volume":"130","author":"Weller","year":"2024","journal-title":"Cancer Treat Rev."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib116","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae143","article-title":"Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)","volume":"111","author":"Chao","year":"2024","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canlet.2025.217701_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217701_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217132","article-title":"The intersection of the nervous system and breast cancer","volume":"598","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib119","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2017.88","article-title":"Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics","volume":"13","author":"Argyriou","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.6004\/jnccn.2022.7074","article-title":"Patient-reported outcome measures in chemotherapy-induced peripheral neurotoxicity: defining minimal and clinically important changes","volume":"21","author":"Li","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib121","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol Ther"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jns.12616","article-title":"Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: a file-based observational study","volume":"29","author":"Argyriou","year":"2024","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/biology13010061","article-title":"The role of NMNAT2\/SARM1 in neuropathy development","volume":"13","author":"Tarasiuk","year":"2024","journal-title":"Biology"},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib124","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/0008-5472.CAN-20-2799","article-title":"Pronociceptive roles of schwann cell-derived galectin-3 in taxane-induced peripheral neuropathy","volume":"81","author":"Koyanagi","year":"2021","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.23736\/S1973-9087.24.08197-8","article-title":"Conservative non-pharmacological treatments for chemotherapy-induced peripheral neuropathies in women treated for breast cancer: a systematic review","volume":"60","author":"Ronconi","year":"2024","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"10.1016\/j.canlet.2025.217701_bib126","doi-asserted-by":"crossref","DOI":"10.1177\/17448069231185694","article-title":"Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats","volume":"19","author":"Mansooralavi","year":"2023","journal-title":"Mol. Pain"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib127","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13311-023-01346-8","article-title":"The therapeutic potential of antioxidants in chemotherapy-induced peripheral neuropathy: evidence from preclinical and clinical studies","volume":"20","author":"Zhou","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib128","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41401-024-01301-z","article-title":"Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice","volume":"45","author":"Lu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"53\u20139","key":"10.1016\/j.canlet.2025.217701_bib129","article-title":"Predictors of cognitive decline in people with cancer undergoing chemotherapy","volume":"27","author":"Oh","year":"2017","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.canlet.2025.217701_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217241","article-title":"Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: current evidence and future directions","volume":"604","author":"Gang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217701_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217203","article-title":"Is tumor microenvironment important for targeted therapy in lung cancer?","volume":"604","author":"Sun","year":"2024","journal-title":"Cancer Lett."},{"issue":"102\u20139","key":"10.1016\/j.canlet.2025.217701_bib132","article-title":"Autoimmune paraneoplastic syndromes associated to lung cancer: a systematic review of the literature","volume":"106","author":"Durieux","year":"2017","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib133","first-page":"67","article-title":"Paraneoplastic neurologic disorders","volume":"23","author":"Gilligan","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib134","first-page":"80","article-title":"Paraneoplastic neurological syndromes of small cell lung cancer","volume":"33","author":"Barahman","year":"2024","journal-title":"Postep Psychiatr Neurol"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jon.13060","article-title":"Autoimmune-mediated encephalitis and mimics: a neuroimaging review","volume":"33","author":"Liang","year":"2023","journal-title":"J. Neuroimaging"},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib136","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib189","first-page":"881","article-title":"The expression of the Hu (paraneoplastic encephalomyelitis\/sensory neuronopathy) antigen in human normal and tumor tissues","volume":"141","author":"Dalmau","year":"1992","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2990.2007.00909.x","article-title":"Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome","volume":"34","author":"Aboul-Enein","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib191","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib192","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0028-3886.121941","article-title":"Paraneoplastic CRMP-5 basal ganglionitis and limbic encephalitis in an elderly Indian lady","volume":"61","author":"Maramattom","year":"2013","journal-title":"Neurol. India"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib193","first-page":"302","article-title":"Predominant downgaze ophthalmoparesis in anti-Hu encephalomyelitis","volume":"16","author":"Schiff","year":"1996","journal-title":"J. Neuro Ophthalmol."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib194","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity","volume":"82","author":"Mas","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3171\/JNS\/2008\/109\/10\/0742","article-title":"Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis","volume":"109","author":"Weimer","year":"2008","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib196","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/CNV-120030214","article-title":"ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features - correlation of clinical improvement with tumor response","volume":"22","author":"Erlich","year":"2004","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib197","first-page":"318","article-title":"Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature","volume":"149","author":"Mancuso","year":"2011","journal-title":"Arch. Ital. Biol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib198","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2169\/internalmedicine.43.602","article-title":"Paraneoplastic cerebellar degeneration (PCD) associated with squamous cell carcinoma of the lung","volume":"43","author":"Konishi","year":"2004","journal-title":"Internal Medicine"},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib199","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00873520","article-title":"Central alveolar hypoventilation associated with paraneoplastic brain-stem encephalitis and anti-hu antibodies","volume":"241","author":"Ball","year":"1994","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/NCC:4:2:137","article-title":"Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-I antibody and small-cell lung cancer","volume":"4","author":"Lee","year":"2006","journal-title":"Neurocritical Care"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib201","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ana.20529","article-title":"Amphiphysin autoimmunity: paraneoplastic accompaniments","volume":"58","author":"Pittock","year":"2005","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0035-3787(04)70863-2","article-title":"Chorea-athetosis in the anti-Hu syndrome","volume":"160","author":"Dorban","year":"2004","journal-title":"Rev. Neurol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib203","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jocn.2008.08.041","article-title":"Chorea, Transverse myelitis, neuropathy and a distinctive MRI: paraneoplastic manifestations of probable small cell lung cancer","volume":"16","author":"Kleinig","year":"2009","journal-title":"J. Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jnnp.69.4.512","article-title":"Chorea resulting from paraneoplastic striatal encephalitis","volume":"69","author":"Tani","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib205","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/1097-0142(19840301)53:5<1115::AID-CNCR2820530517>3.0.CO;2-W","article-title":"Necrotizing myelopathy associated with malignancy - a clinicopathologic study of 2 cases and literature-review","volume":"53","author":"Ojeda","year":"1984","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib206","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00415-003-0213-2","article-title":"Paraneoplastic necrotizing myelopathy with hypertrophy of the cauda equina","volume":"250","author":"Lins","year":"2003","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib207","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-009-0112-0","article-title":"A possible paraneoplastic neuromyelitis optica associated with lung cancer","volume":"30","author":"De Santis","year":"2009","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib208","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1352458515572241","article-title":"Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4","volume":"21","author":"Iorio","year":"2015","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib209","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1992.01080130050025","article-title":"Management and monitoring of cancer-associated retinopathy","volume":"110","author":"Keltner","year":"1992","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-5002(98)00062-2","article-title":"Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma","volume":"22","author":"Salgia","year":"1998","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib211","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.lungcan.2007.02.015","article-title":"Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy","volume":"57","author":"Kobayashi","year":"2007","journal-title":"Lung Cancer"},{"issue":"23","key":"10.1016\/j.canlet.2025.217701_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315056","article-title":"Non-small cell lung cancer targeted therapy: drugs and mechanisms of drug resistance","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib138","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.21.01626","article-title":"Targeted therapies for lung cancer patients with oncogenic driver molecular alterations","volume":"40","author":"Tan","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"35\u201345","key":"10.1016\/j.canlet.2025.217701_bib139","article-title":"Interleukin-1\u03b2 induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model","volume":"228","author":"Labus","year":"2014","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib140","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/s41467-022-34889-z","article-title":"Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer","volume":"13","author":"Adua","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib141","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.devcel.2024.01.010","article-title":"Astrocyte-induced mGluR1 activates human lung cancer brain metastasis via glutamate-dependent stabilization of EGFR","volume":"59","author":"Ishibashi","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2025.217701_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103194","article-title":"Molecular testing and targeted therapy for non-small cell lung cancer: current status and perspectives","volume":"157","author":"Imyanitov","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"29","key":"10.1016\/j.canlet.2025.217701_bib143","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1200\/JCO.24.00581","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib144","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoncol.2023.0459","article-title":"Adjuvant treatments for surgically resected non-small cell lung cancer harboring EGFR mutations: a review","volume":"9","author":"Passaro","year":"2023","journal-title":"JAMA Oncol."},{"issue":"31","key":"10.1016\/j.canlet.2025.217701_bib145","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1200\/JCO.22.00859","article-title":"Lorlatinib in frontline therapy for ALK+ advanced non-small-cell lung cancer: still a matter of debate?","volume":"40","author":"P\u00e9ROL","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.canlet.2025.217701_bib146","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1200\/JCO.21.02278","article-title":"Post hoc analysis of lorlatinib intracranial efficacy and safety in patients with ALK-positive advanced non-small-cell lung cancer from the phase III CROWN study","volume":"40","author":"Solomon","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.canlet.2025.217701_bib147","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2217\/fon-2023-0014","article-title":"Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events","volume":"19","author":"Kilickap","year":"2023","journal-title":"Future Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib148","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.20.03025","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small-cell lung cancer","volume":"39","author":"Dziadziuszko","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib149","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib150","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"Suppl_8","key":"10.1016\/j.canlet.2025.217701_bib151","doi-asserted-by":"crossref","first-page":"viii23","DOI":"10.1093\/annonc\/mdz282","article-title":"TRK inhibitors in TRK fusion-positive cancers","volume":"30","author":"Drilon","year":"2019","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib152","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtho.2022.09.219","article-title":"Factors associated with developing neurocognitive adverse events in patients receiving lorlatinib after progression on other targeted therapies","volume":"18","author":"Dagogo-Jack","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"suppl_1","key":"10.1016\/j.canlet.2025.217701_bib212","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"issue":"25","key":"10.1016\/j.canlet.2025.217701_bib213","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217701_bib214","first-page":"761","article-title":"Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib","volume":"7","author":"Liang","year":"2014","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1758834016687262","article-title":"Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications","volume":"9","author":"Juan","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.canlet.2025.217701_bib216","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.2147\/DDDT.S194231","article-title":"Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives","volume":"13","author":"Lavacchi","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.canlet.2025.217701_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030366","article-title":"Newer-generation EGFR inhibitors in lung cancer: how are they best used?","volume":"11","author":"Le","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib218","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/2278-330X.110506","article-title":"Crizotinib: a comprehensive review","volume":"2","author":"Sahu","year":"2013","journal-title":"South Asian J Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib219","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.21037\/tlcr-20-331","article-title":"How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)","volume":"9","author":"Xia","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib220","first-page":"719","article-title":"[Pharmacology and clinical evaluation of ensartinib hydrochloride capsule]","volume":"23","author":"Wang","year":"2020","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib221","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jamaoncol.2021.3523","article-title":"Ensartinib vs crizotinib for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer: a randomized clinical trial","volume":"7","author":"Horn","year":"2021","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2025.217701_bib222","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11912-021-01078-y","article-title":"ROS1 targeted therapies: current status","volume":"23","author":"Azelby","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib223","article-title":"Focus on ROS1-positive non-small cell lung cancer (NSCLC): crizotinib, resistance mechanisms and the newer generation of targeted therapies","volume":"12","author":"D'Angelo","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.canlet.2025.217701_bib224","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062916","article-title":"The challenge and opportunity of NTRK inhibitors in non-small cell lung cancer","volume":"23","author":"Qin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123608","article-title":"Efficacy of dabrafenib plus trametinib combination in patients with BRAF V600e-mutant NSCLC in real-world setting: GFPC 01-2019","volume":"12","author":"Auliac","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib226","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa2004407","article-title":"Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations","volume":"383","author":"Paik","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217701_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102173","article-title":"Capmatinib for patients with non-small cell lung cancer with MET exon 14 skipping mutations: a review of preclinical and clinical studies","volume":"95","author":"Wu","year":"2021","journal-title":"Cancer Treat Rev."},{"issue":"17","key":"10.1016\/j.canlet.2025.217701_bib228","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174415","article-title":"RET inhibitors in non-small-cell lung cancer","volume":"13","author":"Cascetta","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.canlet.2025.217701_bib229","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS(G12C) inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100260","article-title":"Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations","volume":"6","author":"Riudavets","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2025.217701_bib231","first-page":"103","article-title":"Spotlight on trastuzumab deruxtecan (DS-8201,T-DXd) for HER2 mutation positive non-small cell lung cancer","volume":"12","author":"Azar","year":"2021","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib153","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166557","article-title":"Small-cell lung cancer brain metastasis: from molecular mechanisms to diagnosis and treatment","volume":"1868","author":"Zhu","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib156","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann. Oncol."},{"issue":"152\u20139","key":"10.1016\/j.canlet.2025.217701_bib157","article-title":"Physiological and pathological functions of neuroserpin: regulation of cellular responses through multiple mechanisms","volume":"62","author":"Lee","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1609828","key":"10.1016\/j.canlet.2025.217701_bib161","article-title":"The adipokine component in the molecular regulation of cancer cell survival, proliferation and metastasis","volume":"27","author":"Umar","year":"2021","journal-title":"Pathol. Oncol. Res."},{"issue":"2","key":"10.1016\/j.canlet.2025.217701_bib162","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1096\/fj.201800428R","article-title":"Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain","volume":"33","author":"Xu","year":"2019","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.canlet.2025.217701_bib164","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41556-023-01241-6","article-title":"Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis","volume":"25","author":"Qu","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217701_bib155","article-title":"Nonlinear elasticity of biological basement membrane revealed by rapid inflation and deflation","volume":"118","author":"Li","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib158","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular Co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"issue":"7586","key":"10.1016\/j.canlet.2025.217701_bib159","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"issue":"1_SUPPL","key":"10.1016\/j.canlet.2025.217701_bib160","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1177\/0271678X20951995","article-title":"Regulation of blood-brain barrier integrity by microglia in health and disease: a therapeutic opportunity","volume":"40","author":"Ronaldson","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217701_bib163","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.canlet.2025.217701_bib165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cell.2021.12.043","article-title":"Cellular architecture of human brain metastases","volume":"185","author":"Gonzalez","year":"2022","journal-title":"Cell"},{"issue":"7\u20138","key":"10.1016\/j.canlet.2025.217701_bib166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2119\/2006-00033.He","article-title":"Differential reactions of microglia to brain metastasis of lung cancer","volume":"12","author":"He","year":"2006","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib167","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","article-title":"Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.canlet.2025.217701_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.591405","article-title":"Lung cancer cells-controlled dkk-1 production in brain metastatic cascade drive microglia to acquire a pro-tumorigenic phenotype","volume":"8","author":"Gan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"13730","key":"10.1016\/j.canlet.2025.217701_bib169","article-title":"A neuronal network of mitochondrial dynamics regulates metastasis","volume":"7","author":"Caino","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.canlet.2025.217701_bib170","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037242","article-title":"Brain metastasis organotropism","volume":"10","author":"Yuzhalin","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"10.1016\/j.canlet.2025.217701_bib171","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.ccell.2023.07.010","article-title":"Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits","volume":"41","author":"Sanchez-Aguilera","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217701_bib172","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.semcancer.2021.12.009","article-title":"Rethinking the chemokine cascade in brain metastasis: preventive and therapeutic implications","volume":"86","author":"Maurya","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217701_bib173","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221097","article-title":"Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinic","volume":"14","author":"Rios-Hoyo","year":"2023","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.canlet.2025.217701_bib174","doi-asserted-by":"crossref","first-page":"20521","DOI":"10.1002\/cam4.6624","article-title":"Neuromodulation as an anticancer strategy","volume":"12","author":"Kumaria","year":"2023","journal-title":"Cancer Med."},{"issue":"15","key":"10.1016\/j.canlet.2025.217701_bib175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15153758","article-title":"Radical tumor denervation activates potent local and global cancer treatment","volume":"15","author":"Mitsou","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2025.217701_bib176","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2023.05.008","article-title":"Advancements in small cell lung cancer","volume":"93","author":"Lee","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2025.217701_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.canlet.2025.217701_bib178","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","article-title":"A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors","volume":"3","author":"Jahchan","year":"2013","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.canlet.2025.217701_bib179","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12739-z","article-title":"Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer","volume":"24","author":"Yao","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217701_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216816","article-title":"Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies","volume":"588","author":"Yokota","year":"2024","journal-title":"Cancer Lett."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:00:32Z","timestamp":1760742032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525002678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":230,"alternative-id":["S0304383525002678"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217701","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intersection between lung cancer and neuroscience: Opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217701"}}